COMPANY
Infinant Health
He is a co-founder of Infinant Health and has co-founded other biotech companies focusing on bioactive foods and biomarkers for early disease diagnosis. Gloria Heiss is a Project Coordinator at Infinant Health, where they supports cross-functional initiatives across clinical operations, finance, marketing, and corporate administration. From company website Source · Oct 13, 2026
Funding and NIH signals
- SEC Form D raise Raised $39.25M (Form D filed Jun 8, 2026). SEC Form D 0000905148-26-002831 (Jun 8, 2026)
Evidence (1 event)
- Jun 8, 2026 · SEC Form D 0000905148-26-002831
Name of Issuer: Infinant Health, Inc.; CIK: 2139235; Address: Sacramento, CA; Submission type: D; Filing date: 2026-06-08; Industry Group: Other Health Care; Date of First Sale: 2026-05-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 118230513; Total Amount Sold: 39247552; Federal exemptions: 06b
- Jun 8, 2026 · SEC Form D 0000905148-26-002831